229 related articles for article (PubMed ID: 17074917)
21. Can beta agonists cause dilated cardiomyopathy?
Choudhary AS; Robinson GM
Heart Lung Circ; 2009 Oct; 18(5):367-9. PubMed ID: 19081299
[TBL] [Abstract][Full Text] [Related]
22. The controversy over long-acting beta agonists: examining the evidence.
Lang DM
Cleve Clin J Med; 2006 Nov; 73(11):973-6, 978, 981-4 passim. PubMed ID: 17128539
[TBL] [Abstract][Full Text] [Related]
23. Salmeterol xinafoate in asthma.
Palmer JB; Oxford JM
JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
[No Abstract] [Full Text] [Related]
24. Misleading data analyses in salmeterol (SMART) study.
Lurie P; Wolfe SM
Lancet; 2005 Oct; 366(9493):1261-2; discussion 1262. PubMed ID: 16214589
[No Abstract] [Full Text] [Related]
25. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
26. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No.
Sears MR
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):600-1. PubMed ID: 7881644
[No Abstract] [Full Text] [Related]
27. Labeling changes for asthma drug salmeterol.
FDA Consum; 2003; 37(6):6. PubMed ID: 14983813
[No Abstract] [Full Text] [Related]
28. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
29. Asthma and the beta 2-agonist controversy: much ado about something.
Lieberman JS; Kane GC
Del Med J; 1995 Dec; 67(12):624-8. PubMed ID: 8557164
[No Abstract] [Full Text] [Related]
30. Is there a problem with inhaled long-acting beta-adrenergic agonists?
Nelson HS
J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
[TBL] [Abstract][Full Text] [Related]
31. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
32. [Inhalation of beta-2 agonists or corticosteroids as single drugs in comparison with combination therapy of patients with COPD].
Steurer-Stey C
Praxis (Bern 1994); 2003 Jul; 92(31-32):1324-5. PubMed ID: 12934343
[No Abstract] [Full Text] [Related]
33. Asthma guidelines.
Jack D
Thorax; 1997 Jul; 52(7):665; author reply 665-6. PubMed ID: 9246148
[No Abstract] [Full Text] [Related]
34. Severe childhood asthma.
Hewer SL
Lancet; 1998 May; 351(9116):1662. PubMed ID: 9620748
[No Abstract] [Full Text] [Related]
35. [Interaction between inhaled corticosteroids and long-acting beta-2-agonists].
Kardos P
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S386-9. PubMed ID: 19941242
[No Abstract] [Full Text] [Related]
36. On-demand relief treatment for asthma.
Joseph J; Badrinath P
Lancet; 2001 Jun; 357(9271):1882-3. PubMed ID: 11417575
[No Abstract] [Full Text] [Related]
37. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
38. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
39. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].
Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H
Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125
[No Abstract] [Full Text] [Related]
40. In children hospitalized for asthma exacerbations, does adding ipratropium bromide to albuterol and corticosteroids improve outcome?
Hayday K; Stevermer JJ
J Fam Pract; 2002 Mar; 51(3):280. PubMed ID: 11978242
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
